Abstract
Mycotoxins are a diverse group of fungal secondary metabolites that most commonly affect humans through their association with food and feed crops. Hundreds of mycotoxins have been identified throughout the world, and it is estimated that one-fourth of the world’s food crops are contaminated with fungi that potentially produce mycotoxins (1). This contamination may affect humans directly or indirectly through their economic effect on domesticated animals (2–4). Some of the most important mycotoxins include the aflatoxins, ochratoxins, cyclopiazonic acid, zearalenone, fumonisins, and tricho-thecenes (2,5–8). Of these substances, the trichothecene mycotoxins are the most likely agents to be used in biowarfare or bioterrorism, having been studied (and probably used) for this purpose in the past. The trichothecene mycotoxins, especially the one denoted T-2, pose a threat for potential use as bioweapons because of their ability to cause both lethal and nonlethal illness and their stability. These toxins may be harmful to humans by topical, inhalation, and oral routes and would probably be used in an aerosolized form. Topical exposure causes rapid skin discomfort and damage, a property that can help to rapidly distinguish T-2 exposure from that of other biological agents. Systemic disease may occur following skin, lung, or gastrointestinal absorption. Systemic illness may include rapid lethality or a subacute syndrome similar to that seen in radiation exposure. Because of the stability of these toxins, small-scale poisoning of food or water supplies is a possible alternate delivery method.
The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as representing the position of the Department of the Army or the Department of Defense.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fink-Gremmels J. Mycotoxins: their implications for human and animal health. Vet Q 1999;21:115–120.
Hollinger K, Ekperigin HE. Mycotoxicosis in food producing animals. Vet Clin North Am Food Anim Pract 1999;15:133–165.
Hussein HS, Brasel JM. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 2001;167:101–134.
Peraica NM, Radic B, Lucic A, Pavlovic M. Toxic effects of mycotoxins in humans. Bull WHO 1999:77:754–766.
Abarca ML, Accensi F, Bragulat MR, Cabanes FJ. Current importance of ochratoxin A-producing Aspergillus spy. J Food Prot 2001;64:903–906.
Coulombe RA. Biological actions of mycotoxins. J Dairy Sci 1999;376:880–891.
Osweiler GD. Mycotoxins. Contemporary issues of food animal health and productivity. Vet Clin North Am Food Anim Pract 2000;16:511–530.
Pitt JI. Toxigenic fungi: which are important? Med Mycol 2000;38(suppl 1):17–22.
Yagen B, Bialer M. Metabolism and pharmacokinetics of T-2 toxin and related trichothecenes. Drug Metab Rev 1993;25:281–323.
Sweeney MJ, Dobson ADW. Mycotoxin production by Aspergillus, Fusarium and Penicillium species. Int J Food Microbiol 1998;43:141–158.
Buck WB, Cote L. Trichothecene mycotoxins. In: Keeler RF, Tu AT, eds. Handbook of Natural Toxins. Vol. 6. Toxicology of Plant and Fungal Compounds Marcel Dekker, New York, 1991, pp. 523–555.
Kortepeter M, ed. T-2 mycotoxins. In: USAMRIID’ s Medical Management of Biologic Casualties Handbook, 4th ed. U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, 2001, pp. 146–153. (available online at http://www.usamriid.army.mil/education/bluebook.html).
Wannemacher RW, Wiener SL. Trichothecene mycotoxins. In: Sidell FR, Takafuji ET, Franz DR, eds, Textbook of Military Medicine: Medical Aspects of Chemical and Biologic Warfare. Borden Institute, Washington, DC, 1997, pp. 655–676.
Ueno Y. Mode of action of trichothecenes. Ann Nutr Aliment 1977;31:885–900.
Creasia DA, Thurman JD, Jones LJ, et al. Acute inhalational toxicity of T-2 mycotoxin in mice. Fund Appl Toxicol 1987;8:230–235.
Ihara T, Sugamata M, Sekijima M, Okumura H, Yoshino N, Ueno Y. Apoptotic cellular damage in mice after T-2 toxin-induced acute toxicosis. Nat Toxins 1997;5:141–145.
Sugamata M, Hattori T, Ihara T, Okumura H, Yoshino N, Ueno Y. Fine structural changes and apoptotic cell death by T-2 mycotoxin. J Toxicol Sci 1998;23(suppl II):148–154.
Naseem SM, Pace JG, Wannemacher RW. A high-performance liquid chromatographic method for determining (3H)T-2 and its metabolites in biological fluids of the cynomolgus monkey. J Anal Toxicol 1995;19:151–156.
Mayer CF. Endemic panmyelotoxicosis in the Russian grain belt. Part one: The clinical aspects of alimentary toxic aleukia (ATA). A comprehensive review. Mil Surg 1953;113:173–189.
Mayer CF. Endemic panmyelotoxicosis in the Russian grain belt. Part two: The botany, phytopathology, and toxicology of Russian cereal food. Mil Surg 1953;113:295–315.
Lutsky I, Mor N, Yagen B, Joffe AZ. The role of T-2 toxin in experimental alimentary toxic aleukia: a toxicity study in cats. Toxicol Appl Pharmacol 1978;43:111–124.
Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir Valley, India. Lancet 1989;1:35–37.
Haig AM. Chemical Warfare in Southeast Asia and Afghanistan. March 22,1982 Report to Congress. US Government Printing Office, Washington, DC, 1982.
Heyndricks A, Sookvanichsilp N, van den Heede M. Detection of trichothecene mycotoxins (yellow rain) in blood, urine and faeces of Iranian soldiers treated as victims of a gas attack. Arch Belges 1984;(suppl): 143–146.
Watson SA, Mirocha CJ, Hayes AW. Analysis of trichothecenes in samples from Southeast Asia associated with “yellow rain.” Fund Appl Toxicol 1984;4:700–717.
Mirocha CJ, Pawlosky RA, Chatterjee K, Watson S, Hayes W. Analysis for Fusarium toxins in various samples implicated in biological warfare in Southeast Asia. J Assoc Off Anal Chem 1983:66:1485–1499.
Rosen JD. Presence of mycotoxins and a made-made material in a “yellow rain” sample. Arch Belges 1984;(suppl):173–176.
Rosen RT, Rosen JD. Presence of four Fusarium mycotoxins and synthetic material in ‘yellow rain.’ Evidence for the use of chemical weapons in Laos. Biomed Mass Snectrom 1982;9.443–450
Ashton PS, Meselson M, Robinson JPP, Seeley TD. Origin of yellow rain. Science 1983;222:366–368.
Dashek WV, Mayfield JE, Llewellyn GC, O’Rear CE, Bata A. Trichothecenes and yellow rain: possible biological warfare agents. Bioessavs 1986:4:27–30.
Marshall E. Yellow rain evidence slowly whittled away. Science 1986;233:18–19.
Nowicke JW, Meselson M. Yellow rain-a palynological analysis. Nature 1984;309:205–206.
Stahl C J, Green CC, Farnum JB. The incident at Tuol Chrey: pathologic and toxicologic examinations of a casualtv after chemical attack. J Forensic Sc; 1985;300.317–337
Biehl ML, Lambert RJ, Haschek WM, Buck WB, Schaeffer DJ. Evaluation of a superactivated charcoal paste and detergent and water in prevention of T-2 toxin-induced local cutaneous effects in topically exposed swine. Fundam Appl Toxicol 1989;13:523–532.
Bunner BL, Wannemacher RW, Dinterman RE, Broski FH. Cutaneous absorption and decontamination of (3H)T-2 toxin in the rat model. J Toxicol Environ Health 1989;26:413–423.
Fairhurst S, Maxwell SA, Scawin JW, Swanston DW. Skin effects of trichothecenes and their amelioration by decontamination. Toxicology 1987;46:307–319.
Liu DK, Wannemacher RW, Snider TH, Hayes TL. Efficacy of the topical skin protectant in advanced development. J Appl Toxicol 1999;19:S41-S45.
Bratich PM, Buck WB, Haschek WM. Prevention of T-2 toxin-induced morphologic effects in the rat by highly activated charcoal. Arch Toxicol 1990;64:251–253.
Buck WB, Bratich PM. Activated charcoal: preventing unnecessary death by poisoning. Vet Med 1986;86:73–77.
Fricke RF, Jorge J. Assessment of efficacy of activated charcoal for treatment of acute T-2 toxin poisoning. Clin Toxicol 1990;28:421–431.
Galey FD, Lambert RJ, Busse M, Buck WB. Therapeutic efficacy of superactive charcoal in rats exposed to oral lethal doses of T-2 toxin. Toxicon 1987;25:493–499.
Poppenga RH, Lundeen GR, Beasley VR, Buck WB. Assessment of a general therapeutic protocol for the treatment of acute T-2 toxicosis in swine. Vet Hum Toxicol 1987;29:237–239
Ryu J, Shiraki N, Ueno Y. Effects of drugs and metabolic inhibitors on the acute toxicity of T-2 toxin in mice. Toxicon 1987;25:743–750.
Fricke RF, Jorge J. Beneficial effect of dexamethasone in decreasing the lethality of acute T-2 toxicosis. Gen Pharmacol 1991:22:1087–1091.
Shohami E, Wisotsky B, Kempski O, Feuerstein G. Therapeutic effect of dexamethasone in T-2 toxicosis. Pharm Res 1987;4:527–530.
Tremel H, Strugala G, Forth W, Fichtl B. Dexamethasone decreases lethality of rats in acute poisoning with T-2 toxin. Arch Toxicol 1985:57:74–75
Fricke RF, Jorge J. Methylthiazolidine-4-carboxylate for treatment of acute T-2 toxin exposure. J Appl Toxicol 1991;11:135–140.
Ohtani K, Nanya T, Aoyama Y, et al. Recombinant human granulocyte colony-stimulating factor accelerates regeneration after T-2 toxin-induced hemopoietic injury and lessens lethality in mice. J Toxicol Sci 1993;18:155–166.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Hospenthal, D.R. (2004). Mycotoxins. In: Roy, M.J. (eds) Physician’s Guide to Terrorist Attack. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-663-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-59259-663-8_14
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9814-1
Online ISBN: 978-1-59259-663-8
eBook Packages: Springer Book Archive